Almonty Industries Inc. (ALM) Competitors & Peers
The 5 largest companies in the same industry as Almonty Industries Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| BHP | Peer | $82.86 | P/E 21.5RSI 52Cap 420.6 B |
| BHPLF | Peer | $38.92 | P/E 20.2RSI 47Cap 197.6 B |
| RTNTF | Peer | $102.31 | P/E 13.9RSI 33Cap 166.4 B |
| RIO | Peer | $86.39 | P/E 11.7RSI 48Cap 141.0 B |
| RTPPF | Peer | $82.55 | P/E 11.2RSI 45Cap 139.5 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- EYPTSupplier
Own 10-K customer-concentration disclosure: AlimeraSciences = 10% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- MCKCustomer
McKesson distributes Alimera's ILUVIEN implants to US clinics.
Model-inferred, unverified — treat as a lead, not evidence - ABBVCompetitor
ILUVIEN competes with AbbVie's Ozurdex implant for diabetic macular edema.
Model-inferred, unverified — treat as a lead, not evidence - GKOSCompetitor
Competes in developing specialty micro-implants and ophthalmic treatments.
Model-inferred, unverified — treat as a lead, not evidence